Christoph is an Investment Director at Korys. He started at Korys in 2012 as an investment analyst to support the three investment lines. Since 2015, he has been primarily focusing on the firm’s life science activities in Direct and Fund investments.
Christoph’s career started in investment banking at BNP Paribas Fortis’ corporate finance department in Paris. He then moved to San Francisco to join biotech company iPierian.
Captivated by the science, he subsequently decided to go back to college, enrolling at KU Leuven for the Bioengineering program. Christoph earned a MSc in Bioengineering, a MSc in Applied Economics at the KU Leuven (Belgium) and holds a MSc in International Management from the IAE Aix-en-Provence (France).